Australia markets closed

Enfusion, Inc. (ENFN)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
9.67+0.03 (+0.31%)
At close: 04:00PM EDT
9.67 0.00 (0.00%)
After hours: 04:04PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
181,616
174,535
150,349
111,700
79,565
Cost of revenue
60,513
57,641
47,100
31,845
21,358
Gross profit
121,103
116,894
103,249
79,855
58,207
Operating expenses
Research development
22,013
19,893
17,163
153,400
6,318
Selling general and administrative
92,934
85,053
98,050
202,339
45,815
Total operating expenses
114,947
104,946
115,213
355,739
52,133
Operating income or loss
6,156
11,948
-11,964
-275,884
6,074
Interest expense
-
-
-
4,594
1,662
Total other income/expenses net
-2,106
-2,105
-638
-1,185
82
Income before tax
5,516
11,484
-12,189
-281,663
4,494
Income tax expense
1,718
2,231
1,074
579
433
Income from continuing operations
3,798
9,253
-13,263
-282,242
4,061
Net income
2,541
6,025
-7,654
-158,317
4,061
Net income available to common shareholders
2,621
6,331
-8,608
-187,789
4,061
Basic EPS
-0.10
-
-0.10
-2.26
0.06
Diluted EPS
-0.10
-
-0.10
-2.26
0.06
Basic average shares
85,393
-
85,393
83,045
64,067
Diluted average shares
85,393
-
85,393
83,045
64,067